Belfius Bank is a banking institution based in Brussels, Belgium, established in 1996 to serve the financial needs of local authorities and the broader community. The bank focuses on collecting savings deposits and investments through its distribution networks across Belgium. It reinvests these funds into society by providing loans to individuals, self-employed individuals, small and medium-sized enterprises, as well as corporate, public, and social institutions. With a diverse range of services, Belfius Bank also engages in sectors such as insurance and life sciences. The governance and management of the bank's assets are overseen by its Board of Directors, ensuring responsible stewardship and alignment with community interests.
Chairman of the Management Board of Belfius Insurance
Marc Raisière
CEO and Board Member
Past deals in Belgium
Easyvest
Venture Round in 2024
Easyvest is a financial advisory firm based in Belgium that focuses on helping individuals grow their investments in a personalized and straightforward manner. The company offers online portfolio management services that guide clients in selecting appropriate asset classes and financial products. Easyvest provides consulting on investment portfolios and pension plans, assisting clients in designing risk-efficient model portfolios and recommending strategies to optimize returns while minimizing risk. By prioritizing education and affordability, Easyvest aims to make financial growth accessible to all Belgians.
Hoplr
Venture Round in 2023
Hoplr - pronounced "hopler" - is a Belgian initiative that was founded in 2014 by Jennick Scheerlinck and Jonas Heirwegh, based on a social vision and conviction. Hoplr shifts the focus from the individual to the local community. Harness the power of the collective to anticipate the societal challenges of tomorrow: social cohesion, inclusion, aging, care and citizen participation. Connect online, meet offline. Social cohesion, offline meetings and involvement are the basic requirements to achieve meaningful inclusion and citizen participation. Via Hoplr, citizens get access to the social capital in their neighbourhood: material, knowledge, time, volunteers and infrastructure,... Only this way, we can evolve towards more caring and sustainable smart cities. Hoplr receives "Seal of Excellence" from the European Commission for corona relevant innovation, implementation and impact.
Hoplr
Series A in 2019
Hoplr - pronounced "hopler" - is a Belgian initiative that was founded in 2014 by Jennick Scheerlinck and Jonas Heirwegh, based on a social vision and conviction. Hoplr shifts the focus from the individual to the local community. Harness the power of the collective to anticipate the societal challenges of tomorrow: social cohesion, inclusion, aging, care and citizen participation. Connect online, meet offline. Social cohesion, offline meetings and involvement are the basic requirements to achieve meaningful inclusion and citizen participation. Via Hoplr, citizens get access to the social capital in their neighbourhood: material, knowledge, time, volunteers and infrastructure,... Only this way, we can evolve towards more caring and sustainable smart cities. Hoplr receives "Seal of Excellence" from the European Commission for corona relevant innovation, implementation and impact.
ImCyse
Debt Financing in 2019
ImCyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, that specializes in developing active immunotherapies aimed at treating and preventing severe chronic autoimmune diseases linked to immune system disruptions. Founded in 2010, ImCyse utilizes a unique technology platform that focuses on the administration of Imotopes™, specifically modified peptides that generate cytolytic CD4 T-cells. These T-cells selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, targeting the underlying causes of diseases like type 1 diabetes and multiple sclerosis. ImCyse's innovative approach not only aims to provide therapeutic alternatives where none exist but also seeks to cure patients without compromising their immune defenses. The company has demonstrated proof of concept across several indications and has successfully completed its first clinical trial for type 1 diabetes, yielding promising results while developing additional Imotopes™ for various autoimmune conditions.
Hoplr
Series A in 2018
Hoplr - pronounced "hopler" - is a Belgian initiative that was founded in 2014 by Jennick Scheerlinck and Jonas Heirwegh, based on a social vision and conviction. Hoplr shifts the focus from the individual to the local community. Harness the power of the collective to anticipate the societal challenges of tomorrow: social cohesion, inclusion, aging, care and citizen participation. Connect online, meet offline. Social cohesion, offline meetings and involvement are the basic requirements to achieve meaningful inclusion and citizen participation. Via Hoplr, citizens get access to the social capital in their neighbourhood: material, knowledge, time, volunteers and infrastructure,... Only this way, we can evolve towards more caring and sustainable smart cities. Hoplr receives "Seal of Excellence" from the European Commission for corona relevant innovation, implementation and impact.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.